CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking

Phadke, Rhushikesh A., Brack, Alison, Fournier, Luke A., Kruzich, Ezra, Sha, Mingqi, Picard, Ines, Johnson, Connor, Stroumbakis, Dimitri, Salgado, Maria, Yeung, Charlotte, Escude Velasco, Berta, Liu, Yen Yu, Cruz-Martín, Alberto·2025·Molecular Psychiatry
DOI 10.1038/s41380-024-02701-7PMC PMC11746135
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-024-02701-7

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 C4 overexpression led to mPFC pyramidal neuron hypoconnectivity through a CR3-independent mechanism. A Left: In utero electroporation (IUE) procedure performed on E16 embryos. GFP-control (Con) represents the transfection of a single plasmid (GFP under the CAG promoter), while C4-OE represents the transfection of two plasmids (GFP and C4, both under the CAG promoter). Right: Representative 60X confocal image of P21-23 L2/3 mPFC neurons transfected with GFP (green). DAPI, cytoarchitecture. White dotted line, pia. Scale bar = 100 μm. B The model depicts the mechanism of spine removal through C3b recognition by the microglia expressing CR3 [54, 77]. C Left: Representative confocal image (60X) of CR3KO-control and CR3KO C4-OE. GFP, white signal. Scale bar = 2 μm. Right: C4-OE in mice lacking the CR3 (red circles) showed decreased dendritic spine density relative to control CR3KO mice (blue squares). t-test. *p < 0.05. D Structure of wt C4 and C4 mutants (C4-ΔC345C and C4-GFP). C4 comprises three main chains [27] (β, α and γ) and a highly conserved C-terminal domain known as C345C [27] (cyan). E Left: Representative confocal image (60X) of Control and C4 mutants. Right: OE of wt C4 and mutants C4-GFP-OE and ΔC345C-OE caused a decrease in dendritic spine density relative to GFP-control. Cells were filled with mRuby3 instead of GFP for analysis of the C4-GFP-OE condition. One-way ANOVA. **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar = 2 μm. C N = 13 CR3KO-control dendrites, 3 animals; N = 12 CR3KO-C4-OE dendrites, 3 animals, E N = 9 GFP-control dendrites, N = 10 C4-OE and C4-ΔC345C-OE dendrites, N = 11 C4-GFP dendrites, 3 animals each. All graphs, Mean ± SEM.
Fig. 1 C4 overexpression led to mPFC pyramidal neuron hypoconnectivity through a CR3-independent mechanism. A Left: In utero electroporation (IUE) procedure performed on E16 embryos. GFP-control (Con) represents the transfection of a single plasmid (GFP under the CAG promoter), while C4-OE represents the transfection of two plasmids (GFP and C4, both under the CAG promoter). Right: Representative 60X confocal image of P21-23 L2/3 mPFC neurons transfected with GFP (green). DAPI, cytoarchitecture. White dotted line, pia. Scale bar = 100 μm. B The model depicts the mechanism of spine removal through C3b recognition by the microglia expressing CR3 [54, 77]. C Left: Representative confocal image (60X) of CR3KO-control and CR3KO C4-OE. GFP, white signal. Scale bar = 2 μm. Right: C4-OE in mice lacking the CR3 (red circles) showed decreased dendritic spine density relative to control CR3KO mice (blue squares). t-test. *p < 0.05. D Structure of wt C4 and C4 mutants (C4-ΔC345C and C4-GFP). C4 comprises three main chains [27] (β, α and γ) and a highly conserved C-terminal domain known as C345C [27] (cyan). E Left: Representative confocal image (60X) of Control and C4 mutants. Right: OE of wt C4 and mutants C4-GFP-OE and ΔC345C-OE caused a decrease in dendritic spine density relative to GFP-control. Cells were filled with mRuby3 instead of GFP for analysis of the C4-GFP-OE condition. One-way ANOVA. **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar = 2 μm. C N = 13 CR3KO-control dendrites, 3 animals; N = 12 CR3KO-C4-OE dendrites, 3 animals, E N = 9 GFP-control dendrites, N = 10 C4-OE and C4-ΔC345C-OE dendrites, N = 11 C4-GFP dendrites, 3 animals each. All graphs, Mean ± SEM.CC BY-NC-ND · PubMed Central
Fig. 2 SNX27 interacts with C4 and is essential for normal dendritic spine formation of L2/3 PFC neurons. A Western blot (WB) showing co-IP from HEK293T cells transfected with SNX27 and either C4, C4-ΔC345C or C4-GFP plasmids. The presence of proteins was detected by Western blotting in cell lysates (Input). Interaction of wt C4 and C4 mutants with SNX27 was detected by Western blotting of co-IP against FLAG-tagged SNX27 (IP: FLAG). Protein molecular weights, kilodaltons (kDa). + indicated the presence of wild type protein. B Left: Representative confocal image (60X) of scr-shRNA control (solid blue triangles), shSNX27 (solid red triangles), C4-OE + shSnx27 (orange open circles) and C4-OE (red open circles). GFP, white signal. Scale bar = 2 μm. Right: SNX27 KD and C4-OE + SNX27 KD led to a decrease in spine density relative to scr-shRNA to the same levels as C4-OE. One-way ANOVA. *p < 0.05, **p < 0.01. C Representative STED images (60X) showing GFP-positive dendritic spine (white), SNX27 (green) and C4 (magenta) of DIV 14 cultured PFC neurons. White dotted line indicates spine morphology. Scale bar = 0.5 μm. D Normalized intensity profile of a line drawn through a spine head with SNX27 and C4 colocalized clusters in (A) showing intensities of GFP (gray line), SNX27 (green) and C4 (magenta). E Orthogonal views of (C) are shown (XY, YZ and XZ). Yellow arrowhead, SNX27 and C4 colocalization in the spine. F Representative STED images (60X). White dotted line, dendritic morphology. Scale bar = 2 μm. G Analysis C4 and SNX27 signals showed that approximately 41% of C4 area colocalized with SNX27 and approximately 44% of SNX27 area colocalized with C4 in spines and dendrites. H Representative confocal image (40X) of C4-GFP signal in electroporated L2/3 neurons. Scale bar = 15 μm. Boxes outlined by magenta and yellow show zoomed-in views of the insets, respectively. Scale bar = 5 μm. I 3D surface reconstructions of the insets in magenta and yellow, respectively, from (H). Scale bar = 2 μm. B N = 10 scr-shRNA control, shSnx27 and C4-OE + shSnx27 dendrites, N = 11 C4-OE dendrites, 3 animals each. All graphs, Mean ± SEM. F, G N = 7 dendritic segments, from 3 cells. All graphs, Mean ± SEM.
Fig. 2 SNX27 interacts with C4 and is essential for normal dendritic spine formation of L2/3 PFC neurons. A Western blot (WB) showing co-IP from HEK293T cells transfected with SNX27 and either C4, C4-ΔC345C or C4-GFP plasmids. The presence of proteins was detected by Western blotting in cell lysates (Input). Interaction of wt C4 and C4 mutants with SNX27 was detected by Western blotting of co-IP against FLAG-tagged SNX27 (IP: FLAG). Protein molecular weights, kilodaltons (kDa). + indicated the presence of wild type protein. B Left: Representative confocal image (60X) of scr-shRNA control (solid blue triangles), shSNX27 (solid red triangles), C4-OE + shSnx27 (orange open circles) and C4-OE (red open circles). GFP, white signal. Scale bar = 2 μm. Right: SNX27 KD and C4-OE + SNX27 KD led to a decrease in spine density relative to scr-shRNA to the same levels as C4-OE. One-way ANOVA. *p < 0.05, **p < 0.01. C Representative STED images (60X) showing GFP-positive dendritic spine (white), SNX27 (green) and C4 (magenta) of DIV 14 cultured PFC neurons. White dotted line indicates spine morphology. Scale bar = 0.5 μm. D Normalized intensity profile of a line drawn through a spine head with SNX27 and C4 colocalized clusters in (A) showing intensities of GFP (gray line), SNX27 (green) and C4 (magenta). E Orthogonal views of (C) are shown (XY, YZ and XZ). Yellow arrowhead, SNX27 and C4 colocalization in the spine. F Representative STED images (60X). White dotted line, dendritic morphology. Scale bar = 2 μm. G Analysis C4 and SNX27 signals showed that approximately 41% of C4 area colocalized with SNX27 and approximately 44% of SNX27 area colocalized with C4 in spines and dendrites. H Representative confocal image (40X) of C4-GFP signal in electroporated L2/3 neurons. Scale bar = 15 μm. Boxes outlined by magenta and yellow show zoomed-in views of the insets, respectively. Scale bar = 5 μm. I 3D surface reconstructions of the insets in magenta and yellow, respectively, from (H). Scale bar = 2 μm. B N = 10 scr-shRNA control, shSnx27 and C4-OE + shSnx27 dendrites, N = 11 C4-OE dendrites, 3 animals each. All graphs, Mean ± SEM. F, G N = 7 dendritic segments, from 3 cells. All graphs, Mean ± SEM.CC BY-NC-ND · PubMed Central
Fig. 3 Increasing neuronal levels of SNX27 rescued the C4 hypoconnectivity phenotype. A Representative confocal image (60X) of GFP-positive P21–23 L1 apical tufts in GFP-control (Con, blue squares), C4-OE (red circles), C4-SNX27-OE (purple squares) and SNX27-OE (gray square) in the mPFC. GFP, white signal. Scale bar = 2 μm. B C4 synaptic pathology was rescued by simultaneous OE of SNX27 (C4-SNX27-OE). One-way ANOVA. *p < 0.05, **p < 0.01. C Representative traces of mEPSCs in GFP-control (blue), C4-OE (red), C4-SNX27-OE, (purple), and SNX27-OE (gray) L2/3 mPFC pyramidal neurons from P20–25 animals. Scale bars, 125 ms,10 pA. D mEPSC frequency was decreased in C4-OE relative to GFP-control (Kruskal–Wallis one-way ANOVA. **p < 0.01; GFP-control vs. C4-OE, Dunn’s multiple comparison test. ***p < 0.001) but was rescued when C4 and SNX27 were co-overexpressed (C4-OE vs. C4-SNX27-OE, Dunn’s multiple comparison test. *p < 0.05). SNX27-OE alone did not alter mEPSC frequency relative to GFP-control (Con vs. SNX27-OE, Dunn’s multiple comparison test. p > 0.9999) but was significantly greater than in C4-OE (C4-OE vs. SNX27-OE, Dunn’s multiple comparison test. *p < 0.05). Hz Hertz. There were no differences in the amplitude (E, one-way ANOVA. p = 0.6241), Rise 10–90 (F, Kruskal–Wallis one-way ANOVA. p = 0.4346), and Decay tau (G, one-way ANOVA. p = 0.2122). N = 24 GFP-control cells, from 6 animals. N = 20 C4-OE cells, from 4 animals. B N = 8 control dendrites, N = 9 C4-SNX27-OE dendrites, N = 11 C4-OE and SNX27-OE dendrites, 3 animals each. D–G N = 25 C4-SNX27-OE cells, from 4 animals. N = 22 SNX27-OE cells, from 5 animals. All graphs, Mean ± SEM.
Fig. 3 Increasing neuronal levels of SNX27 rescued the C4 hypoconnectivity phenotype. A Representative confocal image (60X) of GFP-positive P21–23 L1 apical tufts in GFP-control (Con, blue squares), C4-OE (red circles), C4-SNX27-OE (purple squares) and SNX27-OE (gray square) in the mPFC. GFP, white signal. Scale bar = 2 μm. B C4 synaptic pathology was rescued by simultaneous OE of SNX27 (C4-SNX27-OE). One-way ANOVA. *p < 0.05, **p < 0.01. C Representative traces of mEPSCs in GFP-control (blue), C4-OE (red), C4-SNX27-OE, (purple), and SNX27-OE (gray) L2/3 mPFC pyramidal neurons from P20–25 animals. Scale bars, 125 ms,10 pA. D mEPSC frequency was decreased in C4-OE relative to GFP-control (Kruskal–Wallis one-way ANOVA. **p < 0.01; GFP-control vs. C4-OE, Dunn’s multiple comparison test. ***p < 0.001) but was rescued when C4 and SNX27 were co-overexpressed (C4-OE vs. C4-SNX27-OE, Dunn’s multiple comparison test. *p < 0.05). SNX27-OE alone did not alter mEPSC frequency relative to GFP-control (Con vs. SNX27-OE, Dunn’s multiple comparison test. p > 0.9999) but was significantly greater than in C4-OE (C4-OE vs. SNX27-OE, Dunn’s multiple comparison test. *p < 0.05). Hz Hertz. There were no differences in the amplitude (E, one-way ANOVA. p = 0.6241), Rise 10–90 (F, Kruskal–Wallis one-way ANOVA. p = 0.4346), and Decay tau (G, one-way ANOVA. p = 0.2122). N = 24 GFP-control cells, from 6 animals. N = 20 C4-OE cells, from 4 animals. B N = 8 control dendrites, N = 9 C4-SNX27-OE dendrites, N = 11 C4-OE and SNX27-OE dendrites, 3 animals each. D–G N = 25 C4-SNX27-OE cells, from 4 animals. N = 22 SNX27-OE cells, from 5 animals. All graphs, Mean ± SEM.CC BY-NC-ND · PubMed Central
Fig. 4 C4-OE disrupted GluR1-containing AMPAR trafficking in L1 apical tuft dendritic spines. A Model depicting effects of C4 overexpression on GluR1 recycling in dendritic spines. B Representative images (60X) showing a GFP-positive dendritic spine (white), GluR1 (green) and Rab11a (magenta) of P21–23 apical tufts in GFP-controls (blue frame). C Representative images (60X) showing a dendritic spine identified with GFP signal (white), GluR1 (green) and Rab11a (magenta) in C4-OE (red frame). B, C Yellow arrowhead, GluR1 or Rab11a clusters in spines. White-filled arrowhead, GluR1/Rab11a colocalization. White empty arrowhead, non-colocalized GluR1/Rab11a. Spine silhouette, white dotted line. Orthogonal views are shown (XY, YZ and XZ). Scale bar = 2 μm. D C4-OE caused a 47% decrease in the amount of GluR1 colocalized with Rab11a compared to GFP-control. E There was no change in the amount of Rab11a colocalized with GluR1 in C4-OE relative to GFP-control. F C4-OE increased the minimum distance between GluR1 and Rab11a clusters by 35% relative to GFP-control. Green circle: GluR1, Magenta circle: Rab11a. G C4-OE led to a 25% decrease in the overlapping volume between GluR1 and Rab11a relative to GFP-control. Green circle: GluR1, Magenta circle: Rab11a. H Schematic showing the effects of C4-OE on GluR1 degradation in dendritic spines. I Representative images (60X) showing a GFP-positive spine (white), GluR1 (green) and LAMP1 (magenta) in GFP-control (blue frame). J Representative images (60X) showing a GFP-positive spine (white), GluR1 (green) and LAMP1 (magenta) in C4-OE (red frame). I, J Yellow arrowhead, GluR1 or Rab11a clusters in spines. White empty arrowhead, non-colocalized GluR1/LAMP1. White-filled arrowhead, GluR1/LAMP1 colocalization. Spine silhouette, white dotted line. Orthogonal views are shown (XY, YZ and XZ). Scale bar = 2 μm. K C4-OE led to a 145% increase in the amount of GluR1 colocalized with LAMP1. L C4-OE caused a 103% increase in the amount of LAMP1 colocalized with GluR1. M C4-OE induced a 31% decrease in the minimum distance between GluR1 and LAMP1 clusters. Green circle: GluR1, Magenta circle: LAMP1. N Compared to GFP-control, C4-OE did not alter the overlapping volume between GluR1 and LAMP1. Green circle: GluR1, Magenta circle: LAMP1. D, E, K, L N = 8 dendrites, 3 animals for Con and C4-OE. F, G, M, N N = 7 dendrites, 3 animals, Con; and N = 8 dendrites, 3 animals, C4-OE. D–G, K–N t-test. *p < 0.05, **p < 0.01, ***p < 0.001. All graphs, Mean ± SEM.
Fig. 4 C4-OE disrupted GluR1-containing AMPAR trafficking in L1 apical tuft dendritic spines. A Model depicting effects of C4 overexpression on GluR1 recycling in dendritic spines. B Representative images (60X) showing a GFP-positive dendritic spine (white), GluR1 (green) and Rab11a (magenta) of P21–23 apical tufts in GFP-controls (blue frame). C Representative images (60X) showing a dendritic spine identified with GFP signal (white), GluR1 (green) and Rab11a (magenta) in C4-OE (red frame). B, C Yellow arrowhead, GluR1 or Rab11a clusters in spines. White-filled arrowhead, GluR1/Rab11a colocalization. White empty arrowhead, non-colocalized GluR1/Rab11a. Spine silhouette, white dotted line. Orthogonal views are shown (XY, YZ and XZ). Scale bar = 2 μm. D C4-OE caused a 47% decrease in the amount of GluR1 colocalized with Rab11a compared to GFP-control. E There was no change in the amount of Rab11a colocalized with GluR1 in C4-OE relative to GFP-control. F C4-OE increased the minimum distance between GluR1 and Rab11a clusters by 35% relative to GFP-control. Green circle: GluR1, Magenta circle: Rab11a. G C4-OE led to a 25% decrease in the overlapping volume between GluR1 and Rab11a relative to GFP-control. Green circle: GluR1, Magenta circle: Rab11a. H Schematic showing the effects of C4-OE on GluR1 degradation in dendritic spines. I Representative images (60X) showing a GFP-positive spine (white), GluR1 (green) and LAMP1 (magenta) in GFP-control (blue frame). J Representative images (60X) showing a GFP-positive spine (white), GluR1 (green) and LAMP1 (magenta) in C4-OE (red frame). I, J Yellow arrowhead, GluR1 or Rab11a clusters in spines. White empty arrowhead, non-colocalized GluR1/LAMP1. White-filled arrowhead, GluR1/LAMP1 colocalization. Spine silhouette, white dotted line. Orthogonal views are shown (XY, YZ and XZ). Scale bar = 2 μm. K C4-OE led to a 145% increase in the amount of GluR1 colocalized with LAMP1. L C4-OE caused a 103% increase in the amount of LAMP1 colocalized with GluR1. M C4-OE induced a 31% decrease in the minimum distance between GluR1 and LAMP1 clusters. Green circle: GluR1, Magenta circle: LAMP1. N Compared to GFP-control, C4-OE did not alter the overlapping volume between GluR1 and LAMP1. Green circle: GluR1, Magenta circle: LAMP1. D, E, K, L N = 8 dendrites, 3 animals for Con and C4-OE. F, G, M, N N = 7 dendrites, 3 animals, Con; and N = 8 dendrites, 3 animals, C4-OE. D–G, K–N t-test. *p < 0.05, **p < 0.01, ***p < 0.001. All graphs, Mean ± SEM.CC BY-NC-ND · PubMed Central
Fig. 5 C4-OE led to increased levels of GluR1-containing AMPAR in mPFC neurons. A Left: Schematic of dissected GFP-positive tissue from IUE animals, used for isolating cytosolic and synaptosome fractions. Right: Western blot (WB) showing levels of GluR1 with C4 overexpression. GluR1 levels were detected in synaptosome and cytosolic fractions in control and C4-OE conditions. Since C4 was expressed at relatively low levels, it could only be detected when several brains were pooled. Therefore, each lane corresponds to pooled brain lysate from a single litter (6 mice). Protein molecular weights, kilodaltons (kDa, left column). “+” indicates the presence of C4 (top row). Numbers in the bottom row indicate fold change in GluR1 levels relative to control synaptosome and cytosolic fraction. B Left: Schematic of degradation assay in HEK293T cells. Right: WB quantified protein levels of GluR1 in GS and GSC cells with CHX and CHX + MG132 treatment. Protein molecular weights, kilodaltons (kDa, left column). “+” indicates the presence of C4, CHX or MG132. C Left: CHX treatment led to decreased GluR1 levels in GS cells, which was rescued upon application of MG132. Right: GluR1 levels in GSC cells were unaffected by CHX or CHX + MG132 treatments. Light gray circles: DMSO treated cells, Dark gray triangles: CHX treated cells, Dark gray squares: CHX + MG132 treated cells. N = 3 sample replicates per condition. One-way ANOVA. *p < 0.05, **p < 0.01. All graphs, Mean ± SEM.
Fig. 5 C4-OE led to increased levels of GluR1-containing AMPAR in mPFC neurons. A Left: Schematic of dissected GFP-positive tissue from IUE animals, used for isolating cytosolic and synaptosome fractions. Right: Western blot (WB) showing levels of GluR1 with C4 overexpression. GluR1 levels were detected in synaptosome and cytosolic fractions in control and C4-OE conditions. Since C4 was expressed at relatively low levels, it could only be detected when several brains were pooled. Therefore, each lane corresponds to pooled brain lysate from a single litter (6 mice). Protein molecular weights, kilodaltons (kDa, left column). “+” indicates the presence of C4 (top row). Numbers in the bottom row indicate fold change in GluR1 levels relative to control synaptosome and cytosolic fraction. B Left: Schematic of degradation assay in HEK293T cells. Right: WB quantified protein levels of GluR1 in GS and GSC cells with CHX and CHX + MG132 treatment. Protein molecular weights, kilodaltons (kDa, left column). “+” indicates the presence of C4, CHX or MG132. C Left: CHX treatment led to decreased GluR1 levels in GS cells, which was rescued upon application of MG132. Right: GluR1 levels in GSC cells were unaffected by CHX or CHX + MG132 treatments. Light gray circles: DMSO treated cells, Dark gray triangles: CHX treated cells, Dark gray squares: CHX + MG132 treated cells. N = 3 sample replicates per condition. One-way ANOVA. *p < 0.05, **p < 0.01. All graphs, Mean ± SEM.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 65

  1. Schafer DP, Stevens B. Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system. Curr Opin Neurobiol. 2013;23:1034–40. · DOI · Paper page
  2. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164–78. · DOI · Paper page
  3. Sekar A, Bialas AR, De Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177–83. · DOI · Paper page
  4. Druart M, Nosten-Bertrand M, Poll S, Crux S, Nebeling F, Delhaye C, et al. Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes. Mol Psychiatry. 2021:1–13. https://doi.org/10.1038/s41380-021-01081-6. · DOI
  5. Cao W, Zheng D, Wang G, Zhang J, Ge S, Singh M, et al. Modelling biological age based on plasma peptides in Han Chinese adults. Aging. 2020;12:10676–86. · DOI
  6. Carpanini SM, Torvell M, Morgan BP. Therapeutic inhibition of the complement system in diseases of the central nervous system. Front Immunol. 2019;10:362. · DOI
  7. Reus LM, Pasaniuc B, Posthuma D, Boltz T, Ferrari R, Hernandez DG, et al. Gene expression imputation across multiple tissue types provides insight into the genetic architecture of frontotemporal dementia and its clinical subtypes. Biol Psychiatry. 2021;89:825–35. · DOI
  8. Zinellu A, Mangoni AA. Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression. Front Immunol. 2021;12:696085. · DOI
  9. Comer AL, Jinadasa T, Sriram B, Phadke RA, Kretsge LN, Nguyen TPH, et al. Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction. PLoS Biol. 2020;18:e3000604. · DOI
  10. Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan CW, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214–24. · DOI · Paper page
  11. Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369–89. · DOI · Paper page
  12. Mao Y-T, Zhu JX, Hanamura K, Iurilli G, Datta SR, Dalva MB. Filopodia conduct target selection in cortical neurons using differences in signal kinetics of a single kinase. Neuron. 2018;98:767–82.e8. · DOI
  13. Lüscher C, Nicoll RA, Malenka RC, Muller D. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat Neurosci. 2000;3:545–50. · DOI
  14. Kulik YD, Watson DJ, Cao G, Kuwajima M, Harris KM. Structural plasticity of dendritic secretory compartments during LTP-induced synaptogenesis. eLife. 2019;8:e46356.
  15. Harris KM. Structure, development, and plasticity of dendritic spines. Curr Opin Neurobiol. 1999;9:343–8. · DOI
  16. Gasque P, Fontaine M, Morgan BP. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol. 1995;154:4726–33. · DOI
  17. Chen Y, Chu JMT, Chang RCC, Wong GTC. The complement system in the central nervous system: from neurodevelopment to neurodegeneration. Biomolecules. 2022;12:337. · DOI
  18. Veerhuis R, Janssen I, De Groot CJA, Van Muiswinkel FL, Hack CE, Eikelenboom P. Cytokines associated with amyloid plaques in Alzheimer’s disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol. 1999;160:289–99. · DOI
  19. Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol. 2011;48:1592–603. · DOI
  20. West EE, Kemper C. Complosome—the intracellular complement system. Nat Rev Nephrol. 2023;19:426–39. · DOI
  21. Kioussis D, Pachnis V. Immune and nervous systems: more than just a superficial similarity? Immunity. 2009;31:705–10. · DOI · Paper page
  22. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, et al. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996;5:653–66. · DOI · Paper page
  23. Kidmose RT, Laursen NS, Dobó J, Kjaer TR, Sirotkina S, Yatime L, et al. Structural basis for activation of the complement system by component C4 cleavage. Proc Natl Acad Sci USA. 2012;109:15425–30. · DOI
  24. Hussain NK, Diering GH, Sole J, Anggono V, Huganir RL. Sorting Nexin 27 regulates basal and activity-dependent trafficking of AMPARs. Proc Natl Acad Sci USA. 2014;111:11840–5. · DOI · Paper page
  25. Lauffer BEL, Melero C, Temkin P, Lei C, Hong W, Kortemme T, et al. SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane. J Cell Biol. 2010;190:565–74. · DOI · Paper page
  26. Loo LS, Tang N, Al-Haddawi M, Stewart Dawe G, Hong W. A role for sorting nexin 27 in AMPA receptor trafficking. Nat Commun. 2014;5:3176. · DOI · Paper page
  27. Hill TC, Zito K. LTP-induced long-term stabilization of individual nascent dendritic spines. J Neurosci. 2013;33:678–86. · DOI
  28. Huo Y, Gao Y, Zheng Q, Zhao D, Guo T, Zhang S, et al. Overexpression of human SNX27 enhances learning and memory through modulating synaptic plasticity in mice. Front Cell Dev Biol. 2020;8:595357. · DOI
  29. Park M, Salgado JM, Ostroff L, Helton TD, Robinson CG, Harris KM, et al. Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron. 2006;52:817–30. · DOI · Paper page
  30. Nishino H, Saito T, Wei R, Takano T, Tsutsumi K, Taniguchi M, et al. Research articles, cellular/molecular The LMTK1-TBC1D9B-Rab11A cascade regulates dendritic spine formation via endosome trafficking. J Neurosci. 2019;39:9491–502. · DOI
  31. Takahashi T, Svoboda K, Malinow R. Experience strengthening transmission by driving AMPA receptors into synapses. Science. 2003;299:1585–8. · DOI
  32. Esteves da Silva M, Adrian M, Schätzle P, Lipka J, Watanabe T, Cho S, et al. Positioning of AMPA receptor-containing endosomes regulates synapse architecture. Cell Rep. 2015;13:933–43. · DOI · Paper page
  33. Goo MS, Sancho L, Slepak N, Boassa D, Deerinck TJ, Ellisman MH, et al. Activity-dependent trafficking of lysosomes in dendrites and dendritic spines. J Cell Biol. 2017;216:2499–513. · DOI · Paper page
  34. Cheng X-T, Xie Y-X, Zhou B, Huang N, Farfel-Becker T, Sheng Z-H. Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons. J Cell Biol. 2018;217:3127–39. · DOI · Paper page
  35. Wang X, Zhao Y, Zhang X, Badie H, Zhou Y, Mu Y, et al. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction via modulation of glutamate receptor recycling in Down syndrome. Nat Med. 2013;19:473–80. · DOI · Paper page
  36. Kopec CD, Li B, Wei W, Boehm J, Malinow R. Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J Neurosci. 2006;26:2000–9. · DOI · Paper page
  37. Chandra M, Kendall AK, Jackson LP. Toward understanding the molecular role of SNX27/retromer in human health and disease. Front Cell Dev Biol. 2021;9:642378. · DOI
  38. Pensalfini A, Kim S, Subbanna S, Bleiwas C, Goulbourne CN, Stavrides PH, et al. Endosomal dysfunction induced by directly overactivating Rab5 recapitulates prodromal and neurodegenerative features of Alzheimer’s disease. Cell Rep. 2020;33:108420. · DOI
  39. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10–17. · DOI · Paper page
  40. Cox TM, Cachón-González MB. The cellular pathology of lysosomal diseases. J Pathol. 2012;226:241–54. · DOI
  41. Zaharija B, Bradshaw NJ. Aggregation of disrupted in schizophrenia 1 arises from a central region of the protein. Prog Neuropsychopharmacol Biol Psychiatry. 2024;130:110923. · DOI
  42. Zempel H, Mandelkow E. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 2014;37:721–32. · DOI
  43. Dejanovic B, Wu T, Tsai M-C, Graykowski D, Gandham VD, Rose CM, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models. Nat Aging. 2022;2:837–50. · DOI · Paper page
  44. van der Ende EL, Heller C, Sogorb-Esteve A, Swift IJ, McFall D, Peakman G, et al. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study. J Neuroinflammation. 2022;19:217. · DOI
  45. Xiong C, Liu J, Lin D, Zhang J, Terrando N, Wu A. Complement activation contributes to perioperative neurocognitive disorders in mice. J. Neuroinflammation. 2018;15:254. · DOI
  46. Bohlson SS, Tenner AJ. Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation. Annu Rev Immunol. 2023;41:431–52. · DOI
  47. Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, et al. Negative feedback control of neuronal activity by microglia. Nature. 2020;586:417–23. · DOI · Paper page
  48. Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther. 2020;205:107426. · DOI
  49. Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci. 2003;1003:318–27. · DOI
  50. Shepard N, Baez-Nieto D, Iqbal S, Campbell AJ, Pan JQ, Sheng M, et al. Functional analysis of human GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders reveals distinct pathological mechanism. [Preprint] 2023. Available from: https://doi.org/10.1101/2023.08.02.551645. · DOI
  51. Hasan A, Nitsche MA, Rein B, Schneider-Axmann T, Guse B, Gruber O, et al. Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation. Behav Brain Res. 2011;224:15–22. · DOI · Paper page
  52. Frantseva MV, Fitzgerald PB, Chen R, Möller B, Daigle M, Daskalakis ZJ. Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill leaning. Cereb Cortex. 2008;18:990–6. · DOI
  53. Valstad M, Roelfs D, Slapø NB, Timpe CMF, Rai A, Matziorinis AM, et al. Evidence for reduced long-term potentiation-like visual cortical plasticity in schizophrenia and bipolar disorder. Schizophr Bull. 2021;47:1751–60. · DOI
  54. D’Souza RD, Burkhalter A. A laminar organization for selective cortico-cortical communication. Front Neuroanat. 2017;11:71. · DOI · Paper page
  55. Cruz-Martín A, El-Danaf RN, Osakada F, Sriram B, Dhande OS, Nguyen PL, et al. A dedicated circuit links direction-selective retinal ganglion cells to the primary visual cortex. Nature. 2014;507:358–61. · DOI
  56. Barbas H, Pandya DN. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J Comp Neurol. 1989;286:353–75. · DOI
  57. Abs E, Poorthuis RB, Apelblat D, Muhammad K, Pardi MB, Enke L, et al. Learning-related plasticity in dendrite-targeting layer 1 interneurons. Neuron. 2018;100:684–99.e6. · DOI
  58. Huttenlocher PR. Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic. 1984;88:488–96.
  59. Dalakas MC, Alexopoulos H, Spaeth PJ. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol. 2020;16:601–17. · DOI
  60. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci USA. 2004;101:16–22. · DOI
  61. Comer AL, Sriram B, Yen WW, Cruz-Martín A. A pipeline using bilateral in utero electroporation to interrogate genetic influences on rodent behavior. J Vis Exp. 2020:e61350. https://doi.org/10.3791/61350. · DOI
  62. dal Maschio M, Ghezzi D, Bony G, Alabastri A, Deidda G, Brondi M, et al. High-performance and site-directed in utero electroporation by a triple-electrode probe. Nat Commun. 2012;3:960. · DOI
  63. Beaudoin GMJ, Lee S-H, Singh D, Yuan Y, Ng Y-G, Reichardt LF, et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat Protoc. 2012;7:1741–54. · DOI
  64. Cole RW, Jinadasa T, Brown CM. Measuring and interpreting point spread functions to determine confocal microscope resolution and ensure quality control. Nat Protoc. 2011;6:1929–41. · DOI
  65. Stevens B, Johnson MB. The complement cascade repurposed in the brain. Nat Rev Immunol. 2021;21:624–5. · DOI

Cited by

Sorted by citations

See all 20

Metadata

Authors
Phadke, R. A., Brack, A., Fournier, L. A., Kruzich, E., Sha, M., Picard, I., Johnson, C., Stroumbakis, D., Salgado, M., Yeung, C., Escude Velasco, B., Liu, Y. Y., & Cruz-Martín, A.
ORCID
Venue
Molecular Psychiatry
Publisher
Springer Science and Business Media LLC
Published
2024-09-03
Volume
30
Issue
2
Pages
796-809
ISSN
  • 1359-4184
  • 1476-5578
DOI
10.1038/s41380-024-02701-7
PMC
PMC11746135
Cited by
20
References
13
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1R01MH129732-01)
  • BU | College of Arts and Sciences, Boston University (Brenton R. Lutz Award)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking. https://app.cochat.ai/papers/10.1038/s41380-024-02701-7
The paper
Phadke, R. A., Brack, A., Fournier, L. A., Kruzich, E., Sha, M., Picard, I., Johnson, C., Stroumbakis, D., Salgado, M., Yeung, C., Escude Velasco, B., Liu, Y. Y., & Cruz-Martín, A. (2025). The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking. Molecular Psychiatry. https://doi.org/10.1038/s41380-024-02701-7